CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,539 | -87.6% | 39,396 | -85.7% | 0.00% | -75.0% |
| Q2 2023 | $3,700,436 | +402.3% | 275,330 | +519.7% | 0.00% | +300.0% |
| Q1 2023 | $736,633 | -29.7% | 44,429 | -21.2% | 0.00% | 0.0% |
| Q4 2022 | $1,048,463 | +38.8% | 56,369 | -4.3% | 0.00% | 0.0% |
| Q3 2022 | $755,520 | +187.3% | 58,887 | +57.2% | 0.00% | 0.0% |
| Q2 2022 | $263,000 | -18.1% | 37,451 | -3.4% | 0.00% | 0.0% |
| Q1 2022 | $321,000 | +22.5% | 38,755 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $262,000 | +24.8% | 38,755 | -2.3% | 0.00% | – |
| Q3 2021 | $210,000 | -7.9% | 39,686 | 0.0% | 0.00% | – |
| Q2 2021 | $228,000 | +8.6% | 39,686 | -12.8% | 0.00% | – |
| Q1 2021 | $210,000 | +47.9% | 45,516 | +7.0% | 0.00% | – |
| Q4 2020 | $142,000 | +43.4% | 42,533 | +27.2% | 0.00% | – |
| Q3 2020 | $99,000 | -35.7% | 33,433 | 0.0% | 0.00% | – |
| Q2 2020 | $154,000 | -17.2% | 33,433 | -30.6% | 0.00% | -100.0% |
| Q1 2020 | $186,000 | +2.8% | 48,207 | 0.0% | 0.00% | – |
| Q4 2019 | $181,000 | -12.6% | 48,207 | +23.4% | 0.00% | – |
| Q3 2019 | $207,000 | +38.0% | 39,074 | 0.0% | 0.00% | – |
| Q2 2019 | $150,000 | -28.6% | 39,074 | -5.0% | 0.00% | – |
| Q1 2019 | $210,000 | +165.8% | 41,149 | 0.0% | 0.00% | – |
| Q4 2018 | $79,000 | -49.4% | 41,149 | 0.0% | 0.00% | – |
| Q3 2018 | $156,000 | +21.9% | 41,149 | 0.0% | 0.00% | – |
| Q2 2018 | $128,000 | +62.0% | 41,149 | +24.8% | 0.00% | – |
| Q1 2018 | $79,000 | -38.8% | 32,973 | 0.0% | 0.00% | – |
| Q4 2017 | $129,000 | +55.4% | 32,973 | 0.0% | 0.00% | – |
| Q3 2017 | $83,000 | -8.8% | 32,973 | 0.0% | 0.00% | – |
| Q2 2017 | $91,000 | +82.0% | 32,973 | -22.4% | 0.00% | – |
| Q1 2016 | $50,000 | -51.9% | 42,497 | 0.0% | 0.00% | – |
| Q4 2015 | $104,000 | -18.1% | 42,497 | 0.0% | 0.00% | – |
| Q3 2015 | $127,000 | -27.8% | 42,497 | 0.0% | 0.00% | – |
| Q2 2015 | $176,000 | – | 42,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |